Santen
Satoshi Suzuki is an accomplished executive with extensive experience in corporate strategy and development within the pharmaceutical industry. Currently serving as the Vice President of Corporate Strategy and a Board Director at Fuji Pharma Co. Ltd. since August 2022, Satoshi has held significant roles at Santen since April 2016, including Senior Corporate Officer and General Manager of Santen China. Previous positions include President & CEO at Kyowa CritiCare Co., Ltd. and various leadership roles at Eisai Co., Ltd., where responsibilities spanned corporate strategy, talent innovation, and regional management across multiple divisions. Satoshi holds an MBA from Keio School of Business and a degree from Ibaraki University.
This person is not in any teams
This person is not in any offices
Santen
7 followers
SANTEN PHARMACEUTICAL CO., LTD. is a Japan-based pharmaceutical company engaged in the research, development, manufacturing and sales of pharmaceutical products. The Company has medical pharmaceutical business, OTC drugs business, medical devices business and other businesses. The Company engages in manufacture, sale and clinical development of medical pharmaceutical products, the development, manufacturing and sales of medical equipment, as well as the cleaning business. The Company operates in Japan, Europe, Asia, North America markets.